Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,018 total articles
A recent disclosure indicates that Carl Dambkowski, a director at Oruka Therapeutics, Inc., sold common stock valued at approximately $6.19 million on May 21, 2026. This transaction occurred against a backdrop of significant corporate activity for the company, including substantial public offerings and encouraging interim results from its EVERLAST-…
Executive Vice President James sold shares of Walmart common stock on May 21, 2026. This transaction occurred under a pre-established Rule 10b5-1 trading plan. Separately, the company reported Q1 results that partially met expectations, noting strong sales growth in key areas but also facing headwinds and mixed analyst outlooks.
The RealReal's Chief Accounting Officer, Steve Ming Lo, executed a sale totaling $111,712 in company shares on May 21, 2026. This transaction involved the disposition of 12,077 shares at $9.25 per share, which was done by TheRealReal, Inc. to cover withholding taxes related to an equity award vesting. Separately, the company reported its first quar…
TheRealReal Chief Legal Officer, Todd A. Suko, executed a sale of common stock totaling 17,353 shares valued at $160,515 on May 21, 2026. This transaction was explicitly linked to satisfying withholding taxes related to the vesting of an equity award. Separately, the company reported first quarter financial results for 2026, which revealed a smalle…
John R. Furner, CEO of Walmart Inc., recently completed a sale of company shares totaling approximately $1.63 million. This transaction was executed through a pre-arranged Rule 10b5-1 plan. Separately, the company reported first-quarter earnings that met expectations and demonstrated notable growth in sales and EBIT, leading several major financial…
Director John B. Hess sold 370,000 shares of Chevron's common stock, generating proceeds of approximately $73.4 million on May 20, 2026. This sale was reported to the SEC on May 22, 2026. The transaction occurred while the company saw strong returns over the past year and six months, alongside reports of expanding exploration plans and fluctuating …
Sahi Levesque Rati, the Chief Executive Officer of TheRealReal, Inc., sold a total value of $751,044 worth of company shares on May 21, 2026. This transaction involved the automatic disposition of 81,194 shares at $9.25 per share to cover withholding taxes related to an equity award vesting. The sale occurred against a backdrop of positive Q1 2026 …
Westwood Holdings Group Inc. (NASDAQ:WHG) saw its Director Emerita, Susan M. Byrne, execute multiple stock sales totaling $17,923 between May 20 and May 22, 2026. These transactions were reported as being executed under a pre-scheduled Rule 10b5-1 trading plan.The news comes alongside other developments for the company, including its first quarter …
CEO Mac Armstrong recently divested a portion of his Palomar Holdings shares. This transaction occurs against a backdrop of the company reporting robust first-quarter 2026 financials, significantly beating revenue and earnings expectations. Furthermore, analysts have adjusted price targets while noting continued growth potential for the firm.
GSI Technology Inc.'s VP of Sales, Didier Lasserre, recently conducted stock transactions involving both sales and option exercises. These movements occur as the company navigates market fluctuations and reports on recent operational milestones, including a significant smart city project award in Taiwan.
Director Ian Small sold Lumentum Holdings Inc. stock valued at approximately $4.3 million on May 21, 2026. This transaction occurred amidst positive company news, including Q3 FY2026 earnings that beat expectations and the impending addition of LITE to the Nasdaq-100 Index. The sale was structured as a contribution to an exchange fund.
Robert S. Epstein, a director at Veracyte, Inc., recently sold a significant block of company stock. This transaction occurs against a backdrop of robust financial performance for the first quarter of 2026 and major regulatory milestones for its diagnostic products.The sale involved 10,000 shares, totaling $440,129, with the average selling price c…
Sanjay Datta, President of Capital & Enterprise at Upstart Holdings (NASDAQ:UPST), sold a portion of his common stock. This transaction occurred while the company reported mixed first-quarter 2026 results, though it also announced key leadership appointments and new credit partnerships that reflect ongoing strategic efforts.
Brenda J Lauderback, a director at Wolverine World Wide Inc., recently sold shares totaling $87,340. This transaction occurred against a backdrop of strong operational results for the company in Q1 2026, where earnings per share surpassed forecasts by 13.64%, and revenue also exceeded expectations due to robust international growth and increased de…
Gretchen Zech, a senior vice president at Arrow Electronics, recently sold a substantial amount of company stock. This activity is reported against a backdrop of positive corporate developments for Arrow Electronics (ARW), including outstanding first-quarter 2026 financial results, the announcement of a $1 billion share repurchase program, and favo…
Robert V Gunderson Jr., a director at Andersen Group Inc. (NASDAQ:ANDG), recently acquired shares, signaling internal belief in the company's valuation. This transaction occurs against the backdrop of positive revenue growth reported by Andersen Global, though net income saw a decline attributed to initial public offering expenses.
Michael Smith, Chief Legal Officer at INSMED Inc., executed a sale of company shares totaling $666,982. This transaction occurred against a backdrop where the stock has seen significant declines year-to-date, although recent financial results showed revenue and EPS beating expectations. Analysts have provided mixed guidance, with one firm lowering …
A director at International Bancshares Corp (IBOC) executed a substantial sale of common stock in May 2026. This transaction occurred against the backdrop of recent corporate governance developments, including shareholder elections for directors and changes to bylaws that affect derivative legal proceedings.
A director at SM Energy Co. sold a significant block of company stock in May 2026. This activity takes place against a backdrop of positive corporate developments for SM Energy, including robust first-quarter financial performance, the cancellation of senior notes, and an upgrade to 'Outperform' by Raymond James. The company continues to benefit fr…
Palvella Therapeutics, Inc. (NASDAQ:PVLA) recently reported significant insider transactions involving its Chief Operating Officer, Kathleen Goin. During the period analyzed, Ms. Goin executed a sale of common stock valued at approximately $475,630 on May 20, 2026. Simultaneously, she acquired additional shares through the exercise of vested stock …
DoorDash President and COO Prabir Adarkar sold approximately $2.66 million worth of company stock on May 20, 2026. This sale was reportedly executed to satisfy tax requirements associated with the vesting of restricted stock units (RSUs). The transaction occurred while DoorDash's stock traded at $155.588 per share against a current market price of …
Chief Business Officer Keith Yandell sold a portion of his DoorDash Class A Common Stock following the vesting of restricted stock units. This transaction occurred against a backdrop of mixed company performance, including strong revenue growth but slightly missed earnings expectations, alongside significant industry developments that affect valuat…
A director at Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) recently sold shares of the company's common stock. This sale occurred after the stock had seen significant appreciation over the past year. The transaction takes place against a backdrop of positive clinical study results for MRT-2359 and preclinical data for MRT-55811, alongside varied ana…
Laura A. Williams, Chief Patient Officer at ARDELYX, INC., sold common stock valued at $43,803 on May 21, 2026. This transaction was executed as a 'sell-to-cover' mechanism to satisfy withholding taxes related to the vesting of restricted stock units (RSUs). While the company reported missing both revenue and earnings expectations in Q1 2026, it al…
Gloria Melanie, the Chief Operating Officer at Immunovant, Inc. (NASDAQ:IMVT), sold a block of company shares on May 20, 2026. The divestiture was structured to cover tax obligations related to restricted stock units that vested previously. This activity occurred against a backdrop of strong clinical data for IMVT-1402 and elevated price target inc…
